Previous close | 23.80 |
Open | 17.32 |
Bid | 22.90 |
Ask | 26.10 |
Strike | 18.00 |
Expiry date | 2025-01-17 |
Day's range | 23.80 - 23.80 |
Contract range | N/A |
Volume | |
Open interest | 3 |
There are still lots of FTSE 100 shares on sale despite the index's recent gains. Here's a top pharma stock I think could be too cheap for me to miss. The post Looking for top FTSE 100 value shares? Here’s one I’d buy without hesitation appeared first on The Motley Fool UK.
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
A covered call strategy is one way to slightly reduce the risk on a long stock position while also generating some premium. Further upside in a covered call position in GSK stock is limited above the covered call strike. Let's look at how a covered call trade on GSK, formerly known as GlaxoSmithKline and based in the UK, might take shape.